PUBLICATIONS

• Devi G.  A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer’s Disease.  Front. Aging Neurosci. Vol 15, 2023.
• Devi G. Tauopathies. Chapter in Handbook of Clinical Neurology.  David Younger Section Ed,  Francois Boller, Ed 2023; Elsevier, NY, NY. In Press.
• Devi G. Tolerability and Safety of Aducanumab in a Community Setting.  JAGS 2022; doi/10.1111/jgs.18059
• Devi G. Menopause Related Cognitive Impairment. Annual Meeting, IMS, Lisbon, 2022.
• Tumasian R, Devi G. Off-label transcranial magnetic stimulation in amnestic mild cognitive impairment and Alzheimer’s disease: A twelve-year case series in a single clinic. Brain Stimulation 2021;14;4751-753.
• Devi G, Gitelman D, Press D, Daffner K. Cognitive Impairment in Aging Physicians: Current Challenges and Possible Solutions. Neurol Clin Pract 2021;11;167-174.
• Devi G, Creatura C, Devi-Chou, VR.  Menopause Related Cognitive Impairment.  NEJM 2020:382:24:e91.
• Devi G.  Cognition in Physicians.  General Session 1315 – Physician mental health and cognition across the lifespan. Presentation at the American Psychiatric Association May 19, 2019; Annual Meeting, San Francisco
• Devi G. Alzheimer’s Disease in Physicians – Assessing Professional Competence and Tempering Stigma.  N Engl J Med 2018;378:1073-1075.
• Devi G. Audio Interview: Assessment and support for physicians with Alzheimer’s disease.  Supplement to the N Engl J Med 2018
• Devi G, Scheltens P.  Heterogeneity of Alzheimer’s Disease: Consequence for Drug Trials.  Alzheimer’s Research & Therapy 2018;10;122:1-3.
• Devi G. Menopause Related Cognitive Impairment.  J Obs Gyn 2018;132:1325-1327.(Accompanying Editorial in the Journal).
• Devi G. Creativity in Medicine. Neurology 2015: 84(8):e53-e55.
• Devi G. Book Review: Compact Clinical Guide to Women’s Pain Management: An Evidence-Based Approach for Nurses. J Palliative Care 2014: 30(3):194-194.
• Devi G, Voss H, Levine D, et al.  Open-label, short-term repetitive transcranial magnetic stimulation in Alzheimer’s patients with functional imaging correlates and literature review.  Amer J AD Dementias 2014;29(3):248-255.
• Motor Disorders in Dementia Syndromes. Chapter in Textbook of Motor Disorders (3^rd  Ed). David S. Younger, Ed. 2013; Lippincott Williams and Wilkins, NY, NY.
• Devi G, Sugiguchi F, Pedersen, AT et al.  Current Attitudes on self-use and prescription of hormone therapy among New York City gynaecologists.  Menopause Int 19(3) 2013 :118-123.
• Devi G, Levine D, Voss H, et al. Functional Imaging and Neurocognitive Correlates of Targeted High Frequency Repetitive Transcranial Magnetic Stimulation in Patients with Alzheimer’s Disease. Amer Acad of Neurology Annual Meeting, April 2012, New Orleans.
• Devi G, Shin E, Heier L, et al. An Off-Label Exploratory Study of the Efficacy and Safety of Repetitive Transcranial Magnetic Coil Stimulation (rTMS) in Aphasia in Alzheimer’s disease. Amer Acad of Neurology Annual Meeting, April 2010, Toronto.
• Devi G, Shin E, Voss H et al. An Off-Label Exploratory Study of the Efficacy and Safety of Repetitive Transcranial Magnetic Coil Stimulation (rTMS) in Aphasia in Alzheimer’s disease. Neurology 74(9) Suppl (2) 2010: A480.
• Devi G, Zhivotovshaya E, Schultz S et al. Which Presidents are the most memorable? Amer J Alz. Dis Dem. 2010;25(1):32-36.
• Devi G, Shin E, Kim E, Lo V. AMWA position statement on emergency contraception.J Women’s Health 2009;18(10):1539-40.
• Devi G, Glodowski M, Shin E. AMWA position statement: genetic testing. J Women’s Health 2009;18(6):785-6.
• Devi G, Glodowski M, Shin E. AMWA position statement on abortion and reproductive rights. J Women’s Health. 2009;18(3):299-300.
• Devi G, Shin E, Halper J, Lowe S. Case report on the efficacy and safety of repetitive transcranial magnetic coil stimulation (rTMS) in aphasia in Alzheimer’s disease. European J Neurology 16(Suppl 3) 2009, 335-336.
• Devi G, Shin E, Halper J, Lowe S. Case report on the efficacy and safety of repetitive transcranial magnetic coil stimulation (rTMS) in aphasia in Alzheimer’s disease. European Federation of Neur Sciences, Milan Italy, March 2009.
• Devi G, Lo V, Glodowski M et al. Gynecologists beliefs regarding Hormone Therapy for Alzheimer’s Dementia and depression. North Amer Menopause Soc (NAMS) 20^th Annual Meeting, San Diego, CA Oct 2009
• Devi G, Glodowski M, Lo V et al. Current Opinion of American (New York City) gynecologists on indications and contraindications for Hormone Therapy. North Amer Menopause Soc (NAMS) 20^th Annual Meeting, San Diego, CA Oct 2009
• Devi G, Glodowski M, Torenson A. Hormone therapy self-use versus prescription practices of American gynecologists subsequent to the Women’s Health Initiative Study. 8^th European Congress on Menopause (EMAS) London, UK, May 2009.
• Devi G, Glodowski M, Shin E; American Medical Women’s Association. AMWA position statement: cervical cancer prevention. J Women’s Health. 2009;18(2):153-54.
• Devi G. Neurological Disorders in Women: Chapter in Women’s Global Health and Human Rights.  Murthy P, Smith CL, Eds. 2009, 197-222, Jones & Bartlett, Mass.
• Devi G, Schultz S, Khosrowshahi L et al. A retrospective chart review of the tolerability and efficacy of intravenous immunoglobulin (IVIg) in the treatment of Alzheimer’s disease. J Am Geriatr Soc. 2008;56(4):772-4.
• Devi G, Zhivotovshaya E, Schultz S et al. Which Presidents are the most memorable? European Federation of Neurological Societies, 12^th Congress; Madrid, August 2008.
• Devi G, Sarah S, Lynn K et al. A retrospective chart review of the tolerability and efficacy of Intravenous Immunoglobulin (IVIg) in the treatment of Alzheimer’s disease. Gerontological Society of America, November 2007.
• Devi G, Massimi S, Schultz S et al. A double-blind, placebo-controlled trial of donepezil for the treatment of menopause related cognitive loss. North American Menopause Society Meeting, October 2007.
• Devi G, Massimi S, Schultz S et al. A double blind placebo-controlled trial of donepezil for the treatment of menopause related cognitive loss. Gen Med. 2007; 4(2)352-356.
• Devi G, Hahn K, Massimi S, Zhivotovskaya, E.  The prevalence of memory complaints in a community of peri-menopausal women.  Gen Med.  2005; 2(4)255-264.
• Motor Disorders in Dementia Syndromes. Chapter in Textbook of Motor Disorders (2^nd Ed). David S. Younger, Ed. 2005; 599-606, Lippincott Williams and Wilkins, NY, NY
• Devi G, Williamson J, Ottman R et al.  Early onset Alzheimer’s disease and familial co-aggregation with psychiatric disorders.  J. Neuropsychiatry Clin Neurosci.Winter 2004; 16(1): 57-62.
• Devi G. Book Review: Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles. 3rd Edition. Ed. Ashbury AK, McKhann GM, McDonald WI, et al. Neuropsych Clin Neurosci 15:381-382 Summer 2003
• Devi G. Management of drug and alcohol withdrawal. N Engl J Med. 2003 Jul 24;349(4):405-7.
• Devi G. My patient, the doctor and me, Chapter in This Side of Doctoring: Reflections from Women in Medicine. Eliza Lo Chin, Ed.394 pages, 2002; Sage Pub, Thousand Oaks, CA.
• Devi G, Hahn K, Fox S. Screening for cognitive and depressive symptoms among peri- and post-menopausal women. Presented at the North American Menopause Society Meeting, October 2001.
• Fox S, Devi G.  A 5-minute self-administered screening tool for assessing risk factors in menopausal women. Presented at the North American Menopause Society Meeting, October 2001.
• Devi G, Marrero C. The effectiveness of cognitive rehabilitation for memory and cognitive loss associated with menopause. Presented at the North American Menopause Society Meeting, September 2000.
• Devi G, Silver J. Approaches to memory loss in neuropsychiatric disorders. Seminars in Clinical Neuropsychiatry, 2000;4(5):259-265.
• Devi G. Book Review: Diagnosis and Management of Dementia: A manual for memory disorders teams Ed. Wilcock GK, Bucks RS, Rockwood K. J Neuropsych Clin Neurosci 12:281-282 Spring 2000
• Devi G, Fotiou A, Jyrinji D et al. Novel presenelin 1 mutations associated with early onset of dementia in a family with both early-onset and late-onset Alzheimer Disease.  Arch Neurology 2000;57:1454-57.
• Devi G, Ottman R, Tang MX, et al.  Familial aggregation of Alzhiemer’s disease among Caucasians, African Americans and Caribbean Hispanics in Northern Manhattan Archives of Neurology, 2000; 57: 72-77.
• Massoud F, Devi G, Moroney JT et al. The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: A clinicopathologic study. J Am Geriatr Soc 2000;48:1204-1210.
• Devi G, Quitschke W.  Alois Alzheimer: His life and times.  Alz Dis Assoc Disord . Fall 1999; 13:132-137.
• Devi G, Ottman R, Tang MX, et al. Influence of the APOE genotype on familial aggregation of Alzhiemer’s disease among Caucasians, African Americans and Caribbean Hispanics in Northern Manhattan. Neurology, 1999;53:789-794.
• Devi G, Ottman R, Tang MX, et al.  Familial aggregation of Alzheimer’s disease among Caucasians, African Americans and Caribbean Hispanics in Northern Manhattan Presented at the American Academy of Neurology Meeting, Toronto, April 1999.
• Massoud F, Devi G, Stern Y, et al.  A clinico-pathologic comparison of community-based and clinic-based cohorts of patients with dementia. Archives of Neurology, 1999;56:1368-1373.
• Devi G, Fotiou A, Gonzalez A et al.  Clinical features of very early onset (ages 27-35) familial Alzheimer’s disease (abstract).  J Neuropsychiatry Clin Neurosciences 1999;11 :139
• Devi G, Ottman R, Tang M, et al.  Familial aggregation of Alzheimer’s disease and the influence of the APOE genotype among Caucasians, African Americans and Caribbean Hispanics in Northern Manhattan. Annals Neurology 1998;44:396.
• Devi G, Marder K, Schofield PW et al.  Validity of family history for the diagnosis of dementia among siblings of patients with late onset Alzheimer’s Disease.  Genet Epidemiol 1998;15:215-223.
• Devi G.  Estrogen in Alzheimer’s Disease.  Primary Psychiatry 1997;4(10):58-63.
• Devi G, Loreck R.  Alois Alzheimer: Influential Alienist. Presented at the American Academy of Neurology Meeting, Boston, April 1997.
• Devi G, Loreck R.  Alois Alzheimer: Influential Alienist (abstract).  Neurology 1997;48:263.
• Ramachandran G, Glickman L, Levenson J, Rao C.  The incidence of extrapyramidal syndromes in hospitalized patients with AIDS and a comparison group.  J Neuropsychiatry Clin Neurosciences 1997 ;9 :579-583.
• Dana Consortium on the therapy of HIV dementia and related cognitive disorders.  Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment.  Neurology 1997;49:142-146.
• Dana Consortium on the therapy of HIV dementia and related cognitive disorders.    Clinical confirmation of the American Academy of Neurology Algorithm for HIV-1 associated cognitive/motor disorder.  Neurology 1996;47:1247-53.
• Ramachandran G, Marder K, Tang M, et al.  The Apolipoprotein E genotype and psychiatric manifestations of Alzheimer’s disease.  Neurology 1996;47:256-259.
• Ramachandran G, Porjesz B, Begleiter H, Litke A.  Cognitive evoked potentials in young males at high risk for alcoholism.  Alcohol Clin Exp Res 1996;20(1):9-15.
• Schofield P, Marder K, Dooneief G, Bell K, Chun M, Ramachandran G et al.  Subjective memory complaints predict decline in memory and cognition at 1 year follow-up in individuals with cognitive impairment (abstract).  Neurology 1996;46(suppl):434.